Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121913483
rs121913483
0.820 GeneticVariation BEFREE PATIENT SUMMARY: We propose that APOBEC-mediated mutagenesis can generate clinically relevant driver mutations even within suboptimal motifs, such as in the case of FGFR3 S249C, one of the most common mutations in bladder cancer. 30975452

2019

dbSNP: rs2294008
rs2294008
PSCA ; JRK
0.800 GeneticVariation BEFREE Our meta-analysis supports that the PSCA gene variant rs2294008 polymorphism might contribute to individual susceptibility to bladder cancer. 31008939

2019

dbSNP: rs2294008
rs2294008
PSCA ; JRK
0.800 GeneticVariation BEFREE Cumulative evidence of an association was graded as strong for rs2294008 [odds ratio (OR) = 1.32, P = 5.1 × 10-33], rs2976392 (OR = 1.29, P = 1.8 × 10-8), rs9297976 (OR = 0.75, P = 1.4 × 10-7), rs2976391 (OR = 1.38, P = 6.1 × 10-5) and rs138377917 (OR = 0.53, P = 0.008) with gastric cancer, rs2294008 with bladder cancer (OR = 1.15, P = 8.0 × 10-19), gastritis (OR = 1.35, P = 1.2 × 10-5), duodenal ulcer (OR = 0.68, P = 2.4 × 10-57) and gastric ulcer (OR = 0.88, P = 1.7 × 10-7). 30407486

2019

dbSNP: rs10936599
rs10936599
0.720 GeneticVariation BEFREE At the end of the study, we suggested that there may exist an association between a combination of MYNN rs10936599 and TERC rs2293607 polymorphisms and development of bladder cancer in Turkish population. 30120764

2019

dbSNP: rs1695
rs1695
0.080 GeneticVariation BEFREE Glutathione S-Transferase Pi 1 (GSTP1) Gene 313 A/G (rs1695) polymorphism is associated with the risk of urinary bladder cancer: Evidence from a systematic review and meta-analysis based on 34 case-control studies. 31454540

2019

dbSNP: rs833052
rs833052
0.040 GeneticVariation BEFREE Our meta-analysis suggested that rs3025039 (C > T), rs833052 (C > A) and rs25648 (C > T) polymorphisms of VEGF gene increased susceptibility to BCa risk. 30849545

2019

dbSNP: rs833052
rs833052
0.040 GeneticVariation BEFREE The VEGF gene rs3025039C/T and rs833052C/A variants may contribute to the risk of developing BCa, especially in Asian descendants. 30609111

2019

dbSNP: rs25648
rs25648
0.030 GeneticVariation BEFREE Our meta-analysis suggested that rs3025039 (C > T), rs833052 (C > A) and rs25648 (C > T) polymorphisms of VEGF gene increased susceptibility to BCa risk. 30849545

2019

dbSNP: rs699947
rs699947
0.030 GeneticVariation BEFREE As to ethnicity subgroup analysis, rs699947 and rs3025039 polymorphisms were thought as a risk factor for BCa risk in Asian population, while a decreased association was revealed between rs699947 (C > A) A-allele and BCa risk in African population under dominant, recessive, homozygous, heterozygous and allele contrast genetic models. 30849545

2019

dbSNP: rs217727
rs217727
0.020 GeneticVariation BEFREE Our results provided the evidence that rs217727 in H19 was associated with elevated risk of bladder cancer, which may be a potential biomarker for predicting bladder cancer susceptibility. 29595036

2019

dbSNP: rs3025039
rs3025039
0.020 GeneticVariation BEFREE The VEGF gene rs3025039C/T and rs833052C/A variants may contribute to the risk of developing BCa, especially in Asian descendants. 30609111

2019

dbSNP: rs3025039
rs3025039
0.020 GeneticVariation BEFREE Our meta-analysis suggested that rs3025039 (C > T), rs833052 (C > A) and rs25648 (C > T) polymorphisms of VEGF gene increased susceptibility to BCa risk. 30849545

2019

dbSNP: rs3834129
rs3834129
0.020 GeneticVariation BEFREE Caspase-8 rs3834129 genotypes play a minor role in the personal susceptibility to bladder cancer in Taiwan. 31519577

2019

dbSNP: rs12921862
rs12921862
0.010 GeneticVariation BEFREE The <i>AXIN1</i> gene polymorphisms might implicate in BC risk, and rs12921862 could be a potential forecasting factor for prognosis of BC patients. 31143301

2019

dbSNP: rs138377917
rs138377917
0.010 GeneticVariation BEFREE Cumulative evidence of an association was graded as strong for rs2294008 [odds ratio (OR) = 1.32, P = 5.1 × 10-33], rs2976392 (OR = 1.29, P = 1.8 × 10-8), rs9297976 (OR = 0.75, P = 1.4 × 10-7), rs2976391 (OR = 1.38, P = 6.1 × 10-5) and rs138377917 (OR = 0.53, P = 0.008) with gastric cancer, rs2294008 with bladder cancer (OR = 1.15, P = 8.0 × 10-19), gastritis (OR = 1.35, P = 1.2 × 10-5), duodenal ulcer (OR = 0.68, P = 2.4 × 10-57) and gastric ulcer (OR = 0.88, P = 1.7 × 10-7). 30407486

2019

dbSNP: rs1805105
rs1805105
0.010 GeneticVariation BEFREE Our data revealed that three tag SNPs were associated with an increased risk of BC (rs12921862: <i>P</i> < 0.001, OR (95%CI) = 4.61 (3.13-6.81); rs1805105: <i>P</i> = 0.046, OR (95%CI) = 1.35 (1.00-1.82); and rs370681: <i>P</i> = 0.004, OR (95%CI) = 1.56 (1.15-2.10)). 31143301

2019

dbSNP: rs2067079
rs2067079
0.010 GeneticVariation BEFREE The T G haplotype (rs2067079 and rs6790) increased the risk of bladder cancer in the assessed population (OR (95% CI) = 1.73 (1.18-2.56), adjusted P value = 0.02). 31250374

2019

dbSNP: rs2073859
rs2073859
0.010 GeneticVariation BEFREE PCR-Restriction Fragment Length Polymorphism (RFLP) was used to genotype LIMK2 SNP rs2073859 and multivariate logistic regression applied to assess the relationship between allele frequency and clinical features in 139 BC patients. 30006972

2019

dbSNP: rs2278329
rs2278329
0.010 GeneticVariation BEFREE Patients with bladder cancer and controls did not differ significantly in terms of genotype frequencies and allele frequency distribution of rs2278329 (P = 0.77, OR = 0.97) and rs2292016 (P = 0.39, OR = 1.20) respectively. 30755233

2019

dbSNP: rs2292016
rs2292016
0.010 GeneticVariation BEFREE Patients with bladder cancer and controls did not differ significantly in terms of genotype frequencies and allele frequency distribution of rs2278329 (P = 0.77, OR = 0.97) and rs2292016 (P = 0.39, OR = 1.20) respectively. 30755233

2019

dbSNP: rs2293607
rs2293607
0.010 GeneticVariation BEFREE At the end of the study, we suggested that there may exist an association between a combination of MYNN rs10936599 and TERC rs2293607 polymorphisms and development of bladder cancer in Turkish population. 30120764

2019

dbSNP: rs2735971
rs2735971
0.010 GeneticVariation BEFREE Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population. 29595036

2019

dbSNP: rs2976391
rs2976391
PSCA ; JRK
0.010 GeneticVariation BEFREE Cumulative evidence of an association was graded as strong for rs2294008 [odds ratio (OR) = 1.32, P = 5.1 × 10-33], rs2976392 (OR = 1.29, P = 1.8 × 10-8), rs9297976 (OR = 0.75, P = 1.4 × 10-7), rs2976391 (OR = 1.38, P = 6.1 × 10-5) and rs138377917 (OR = 0.53, P = 0.008) with gastric cancer, rs2294008 with bladder cancer (OR = 1.15, P = 8.0 × 10-19), gastritis (OR = 1.35, P = 1.2 × 10-5), duodenal ulcer (OR = 0.68, P = 2.4 × 10-57) and gastric ulcer (OR = 0.88, P = 1.7 × 10-7). 30407486

2019

dbSNP: rs2976392
rs2976392
PSCA ; JRK
0.010 GeneticVariation BEFREE Cumulative evidence of an association was graded as strong for rs2294008 [odds ratio (OR) = 1.32, P = 5.1 × 10-33], rs2976392 (OR = 1.29, P = 1.8 × 10-8), rs9297976 (OR = 0.75, P = 1.4 × 10-7), rs2976391 (OR = 1.38, P = 6.1 × 10-5) and rs138377917 (OR = 0.53, P = 0.008) with gastric cancer, rs2294008 with bladder cancer (OR = 1.15, P = 8.0 × 10-19), gastritis (OR = 1.35, P = 1.2 × 10-5), duodenal ulcer (OR = 0.68, P = 2.4 × 10-57) and gastric ulcer (OR = 0.88, P = 1.7 × 10-7). 30407486

2019

dbSNP: rs3024270
rs3024270
0.010 GeneticVariation BEFREE Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population. 29595036

2019